Location · Illinois
Clinical trials recruiting in Illinois
890 recruiting studies have at least one site in Illinois; 285 accept healthy volunteers. Studies that need a specific condition are included too, so check each listing.
Want the research companies that run paid Phase 1 studies for healthy volunteers? Paid clinical trial companies in Illinois.
890 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2/Phase 3
A Sequential Phase 2/3 Study of APL2 in Patients With Focal Segmental Glomerulosclerosis
Apellis Pharmaceuticals, Inc.
- Location
- Chicago, IL + 1 other US site
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Pulmovant, Inc.
- Location
- Chicago, IL + 12 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
Vertex Pharmaceuticals Incorporated
- Location
- Chicago, IL + 9 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and…
Novo Nordisk A/S
- Location
- Gurnee, IL + 55 other US sites
- Eligibility basics
- Ages 45+
- RecruitingPhase 2/Phase 3
Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome
Quoin Pharmaceuticals
- Location
- Chicago, IL
- Eligibility basics
- Ages 14+
- Recruiting
MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors
Clinical Nutrition Research Center, Illinois Institute of Technology
- Location
- Chicago, IL
- Eligibility basics
- Ages 40–60
- RecruitingPhase 2
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Cytokinetics
- Location
- Peoria, IL + 23 other US sites
- Eligibility basics
- Ages 40–85
- Recruiting
Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
i-Lumen Scientific AUS PTY LTD
- Location
- Lemont, IL + 5 other US sites
- Eligibility basics
- Ages 60+
- RecruitingPhase 3
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Novartis Pharmaceuticals
- Location
- Chicago, IL + 42 other US sites
- Eligibility basics
- Ages 40–70
- RecruitingPhase 2
Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH
Madrigal Pharmaceuticals, Inc.
- Location
- Chicago, IL + 11 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Procyrion
- Location
- Chicago, IL + 31 other US sites
- Eligibility basics
- Ages 21+
- RecruitingPhase 3
A Study of Pitolisant in Patients With Prader-Willi Syndrome
Harmony Biosciences Management, Inc.
- Location
- Chicago, IL + 18 other US sites
- Eligibility basics
- Ages 6+
- Recruiting
Assessment of CSF Shunt Flow During Activities of Daily Living and Sleep With a Thermal Measurement Device
Rhaeos, Inc.
- Location
- Chicago, IL + 1 other US site
- Eligibility basics
- Ages 2+
- RecruitingPhase 2
Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants Undergoing Open Abdominal Ventral Hernia Repair
AbbVie
- Location
- Evanston, IL + 10 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2/Phase 3
Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Support
Protara Therapeutics
- Location
- Chicago, IL + 5 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
AstraZeneca
- Location
- Chicago, IL + 206 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Safety and Efficacy of J147 in Acute Ischemic Stroke
Abrexa Pharmaceuticals, Inc.
- Location
- Rockford, IL
- Eligibility basics
- Ages 18–90
- RecruitingPhase 1/Phase 2
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
4D Molecular Therapeutics
- Location
- Oak Forest, IL + 19 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 1/Phase 2
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Sanofi Pasteur, a Sanofi Company
- Location
- Chicago, IL + 78 other US sites
- Eligibility basics
- Ages 18–45
- RecruitingPhase 1/Phase 2
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
Otsuka Pharmaceutical Factory, Inc.
- Location
- Chicago, IL
- Eligibility basics
- Ages 35–70
- RecruitingPhase 2
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Boehringer Ingelheim
- Location
- Gurnee, IL + 9 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Amgen
- Location
- Arlington Heights, IL + 193 other US sites
- Eligibility basics
- Ages 50–105
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Kallyope Inc.
- Location
- Chicago, IL + 111 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation
Javelin Medical
- Location
- Rockford, IL + 3 other US sites
- Eligibility basics
- Ages 18+